000 | 05870cam a2200625 i 4500 | ||
---|---|---|---|
001 | ocn868950997 | ||
003 | OCoLC | ||
005 | 20221128212408.0 | ||
006 | m d | ||
007 | cr ||||||||||| | ||
008 | 130312s2013 nyua ob 001 0 eng | ||
010 | _a 2020678387 | ||
040 |
_aDLC _beng _erda _cDLC _dN$T _dOCLCF _dYDXCP _dEBLCP _dSTF _dAU@ _dE7B |
||
019 |
_a923548920 _a923670323 _a928194354 _a929143286 |
||
020 |
_a9781626185098 _q(eBook) |
||
020 | _a1626185093 | ||
020 |
_z1626184607 _q(hardback) |
||
020 |
_z9781626184602 _q(hardback) |
||
035 |
_a635078 _b(N$T) |
||
035 |
_a(OCoLC)868950997 _z(OCoLC)923548920 _z(OCoLC)923670323 _z(OCoLC)928194354 _z(OCoLC)929143286 |
||
072 | 7 |
_aHEA _x039000 _2bisacsh |
|
072 | 7 |
_aMED _x014000 _2bisacsh |
|
072 | 7 |
_aMED _x022000 _2bisacsh |
|
072 | 7 |
_aMED _x112000 _2bisacsh |
|
072 | 7 |
_aMED _x045000 _2bisacsh |
|
049 | _aMAIN | ||
245 | 0 | 0 |
_aMuscular dystrophy : _bcauses and management _c _h[E-Book] |
264 | 1 |
_aNew York : _bNova Biomedical, _c[2013] |
|
300 | _a1 online resource. | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 1 | _aNeurodegenerative diseases--laboratory and clinical research | |
490 | 1 | _aMuscular System - Anatomy, Functions and Injuries | |
504 | _aIncludes bibliographical references and index. | ||
588 | _aDescription based on print version record. | ||
505 | 0 | _a""MUSCULAR DYSTROPHY. CAUSES AND MANAGEMENT""; ""MUSCULAR DYSTROPHY. CAUSES AND MANAGEMENT""; ""Library of Congress Cataloging-in-Publication Data""; ""Contents""; ""Preface""; ""Section 1. Genetic, Environmental Interactions and Evaluation""; ""Chapter 1: Muscular Dystrophy: The Present and Future""; ""Abstract""; ""The Present""; ""The Future""; ""Genetic and Environmental Interaction""; ""References""; ""Chapter 2: History and Pathogenesis of Muscular Dystrophy""; ""Introduction""; ""Muscular Dystrophy: Recognition of Different Forms""; ""Recognition of Severe X-Linked Muscular Dystrophy"" | |
505 | 8 | _a""The Nosographic Era: The Recognition of Limb-Girdle Dystrophies""""The Recognition of Facio-Scapulo Humeral Dystrophy (FSHD)""; ""Therapeutical Trials in DMD""; ""The Molecular Era""; ""References""; ""Chapter 3: Biomarkers and Genetic Risks""; ""Abstract""; ""Defining Biomarkers""; ""Biomarkers in Muscular Dystrophies""; ""Emerging Biomarkers""; ""Critical Parameters for the Choice of Biomarker Assay""; ""Conclusion""; ""References""; ""Chapter 4: Inflammation in Duchenne Muscular Dystrophy""; ""Introduction""; ""General Aspects of Dystrophic Muscle and the Immune Response"" | |
505 | 8 | _a""Hypothesis on a Putative Link between Functional Concepts of the Immune Response and Development of Fibrosis in DMD""""A View on Pathogenesis in DMD with Emphasis on Fibrosis and Inflammation""; ""Modeling DMD, Mediators and Drivers of the Immune Process �a�? What Can We Learn from the Mouse?""; ""Therapy Targeting Immune Processes""; ""Conclusion""; ""References""; ""Chapter 5: MRI Imaging in Muscular Dystrophies""; ""Abstract""; ""Introduction""; ""MRI Scoring and Interpretation""; ""Duchenne Muscular Dystrophy (DMD)""; ""Limb Girdle Muscular Dystrophies""; ""LGMD2A (Calpainopathy)"" | |
505 | 8 | _a""LGMD 2B (Dysferlinopathy)""""LGMD2I (FKRP Defect)""; ""Myotonic Dystrophy Type 1 (DM1)""; ""PROMM or Myotonic Dystrophy Type 2 (DM2)""; ""Congenital Muscular Dystrophies (CMD)""; ""Hyaline Body Myopathy (Scapulo-Peroneal Syndrome)""; ""Emery�a�?Dreifuss Muscular Dystrophy""; ""Bethlem Myopathy""; ""Future Perspectives""; ""References""; ""Chapter 6: Clinical Scales for the Evaluation of Neuromuscular Patients""; ""Abstract""; ""Motor Function""; ""Quality of Life""; ""References""; ""Section 2. Specific Dystrophies""; ""Chapter 7: Dystrophinopathies""; ""Abstract"" | |
505 | 8 | _a""Introduction: An Overview of Dystrophinopathies""""Clinical Description of DMD""; ""Clinical Description of BMD""; ""Clinical Description of Carriers""; ""Molecular Bases of Dystrophinopathies: The DMD Gene""; ""Molecular Bases of Dystrophinopathy: The Dystrophin Protein""; ""Molecular Bases of Dystrophinopathy: Pathogenesis""; ""Diagnosis of Dystrophinopathy""; ""Genetic Counseling and Prevention""; ""Treatment""; ""References""; ""Chapter 8: Scapulo-peroneal Syndromes""; ""Introduction""; ""Case Presentation""; ""Historical Perspective""; ""1. Scapuloperoneal Muscular Dystrophy (SPMD)"" | |
520 | _aMuscular Dystrophies include a heterogeneous series of diseases that range from childhood to adult onset cases, of difficult diagnosis and treatment. This book presents the state of the art in muscular dystrophies, after the molecular revolution. In the field of patients' diagnosis, several advances have been done by recognizing new entities. New techniques such as biochemical, molecular advancements, and the use of muscle MRI are collected that allow rapid diagnosis. Also, advances in therapy and therapeutical trials are presented in Duchenne and other muscular dystrophies and some novel trea. | ||
590 | _aMaster record variable field(s) change: 050, 082 | ||
650 | 0 |
_aMuscular dystrophy. _97054 |
|
700 | 1 |
_aAngelini, C. _q(Corrado), _eeditor. |
|
830 | 0 | _aNeurodegenerative diseases--laboratory and clinical research. | |
830 | 0 | _aMuscular system--anatomy, functions, and injuries series. | |
856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=635078 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
938 |
_aYBP Library Services _bYANK _n11120189 |
||
938 |
_aEBSCOhost _bEBSC _n635078 |
||
938 |
_aebrary _bEBRY _nebr10752217 |
||
938 |
_aProQuest Ebook Central _bEBLB _nEBL2194161 |
||
942 | _n0 | ||
994 |
_a92 _bN$T |
||
999 |
_c91417 _d91417 |